The invention refers to novel propenecarboxylic acid amidoxime derivatives furthermore
N-oxides and/or geometrical isomers and/or optical isomers and/or pharmaceutically
suitable acid addition salts and/or quaternary derivatives thereof. The novel compounds
are suitable for the treatment of a state connected with oxygen deficit and/or
energy deficit, or a disease based on PARP inhibition, especially an autoimmune
or neurodegenerative disease, and/or a viral disease, and/or a disease caused by
a toxic effect.
